NFKB1 and cancer: Resveratrol has been shown to modulate nuclear factor kappa B (NFκB) and AP-1 activation in various cancer cell lines, leading to the speculation that NFκB and AP-1 are potential targets of resveratrol (Banerjee et al. 2002; Kundu and Surh 2004).